Engineering enzymes for cleaner industrial manufacturing
The Centre of Excellence for Biocatalysis, Biotransformations and Biocatalytic Manufacture (CoEBio3) has combined industry-funded PhD training with pioneering biocatalysis research, delivering commercial enzymes, industrial processes and a new pipeline of biotechnology talent.
- The Centre of Excellence for Biocatalysis, Biotransformations and Biocatalytic Manufacture (CoEBio3) has combined pioneering biocatalysis research with industry-focused doctoral training, helping translate enzyme science into industrial applications.
- The programme has commercialised more than 1,000 biocatalysts, with enzymes used at industrial scale and applications developed with international pharmaceutical companies.
- The work is helping establish alternatives to manufacturing processes that rely on fossil-derived materials, hazardous chemicals and energy-intensive steps.
Rethinking chemical manufacturing
Many industrial manufacturing processes rely on fossil-derived raw materials, hazardous chemicals and energy-intensive steps. The challenge is to make complex products from renewable materials under milder conditions. In nature, sequences of enzymes convert simple starting materials into complex products. Researchers from The Centre of Excellence for Biocatalysis, Biotransformations and Biocatalytic Manufacture (CoEBio3) have discovered and engineered new enzyme classes and showed how these could be assembled into multi-step catalytic cascades, creating artificial biosynthetic pathways for complex molecule synthesis.
The programme has delivered new commercial enzymes and efficient biocatalytic processes that have been adopted by pharmaceutical and chemical manufacturers.
From discovery to deployment
CoEBio3 has shaped industrial biocatalysis research, demonstrating how engineered enzymes and multi-enzyme cascades can efficiently deliver valuable synthetic and natural products.
Through their work, CoEBio3 researchers have commercialised more than 1,000 biocatalysts, with enzymes used at industrial scale and multiple applications developed with international pharmaceutical companies.
CoEBio3 has also informed the UK Bioeconomy Strategy and has contributed to a free online industrial biotechnology course reaching more than 10,000 learners.
The new BioProcess Industrial Doctoral Landscape Award (IDLA) builds on the strong foundation provided by CoEBio3, bringing Manchester together with AstraZeneca, Bristol, York and other industrial partners to train doctoral researchers on industry-defined challenges spanning protein engineering, computational biology, process development and biomanufacturing.
Industrial manufacturing is at a turning point. By engineering enzymes to make the complex molecules society needs, we can replace resource-intensive processes with safer, more sustainable alternatives.
Discover how Manchester is developing the next generation of expertise in sustainable biomanufacturing. Visit the BioProcess Industrial Doctoral Landscape Award website